Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-25-032661
Filing Date
2025-11-03
Accepted
2025-11-03 08:00:38
Documents
20
Period of Report
2025-12-02

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A bcda20251101_def14a.htm   iXBRL DEF 14A 796525
6 graph1.jpg GRAPHIC 51010
7 graph2.jpg GRAPHIC 52151
8 proxy_page2.jpg GRAPHIC 82591
9 proxy_pg1.jpg GRAPHIC 101981
  Complete submission text file 0001437749-25-032661.txt   2138606

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bcda-20241231.xsd EX-101.SCH 4575
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20241231_def.xml EX-101.DEF 1750
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20241231_lab.xml EX-101.LAB 1775
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20241231_pre.xml EX-101.PRE 1004
22 EXTRACTED XBRL INSTANCE DOCUMENT bcda20251101_def14a_htm.xml XML 134395
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

EIN.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38999 | Film No.: 251442162
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)